Insider · CIK 0001272354

COHEN RON

Reports to the SEC for 2 companies · HAWTHORNE, NY

sec.gov

Transactions

Companies

Filings

CIK

0001272354

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2023-03-31	Acorda Therapeutics, Inc.Employee Stock Option (right to buy)A Award	Director, President and CEO	AAward	+169K sh	—	—	168,800
2023-03-17	Acorda Therapeutics, Inc.P Purchase	Director, President and CEO	PPurchase	+10K sh	$0.65	+$6,500	149,757
2023-03-16	Acorda Therapeutics, Inc.P Purchase	Director, President and CEO	PPurchase	+10.2K sh	$0.60	+$6,093.6	139,757
2022-03-17	Acorda Therapeutics, Inc.S Sale	Director, President and CEO	SSale	−2,289 sh	$1.70	−$3,894.505	129,601
2021-11-12	Acorda Therapeutics, Inc.Employee Stock Option (right to buy)A Award	Director, President and CEO	AAward	+100K sh	—	—	100,000
2021-09-03	Acorda Therapeutics, Inc.F Tax Payment	Director, President and CEO	FTax Payment	−3,940 sh	$4.38	−$17.3K	131,890
2021-03-03	Acorda Therapeutics, Inc.A Award	Director, President and CEO	AAward	+29K sh	—	—	135,830
2020-09-17	Acorda Therapeutics, Inc.A Award	Director, President and CEO	AAward	+8,543 sh	—	—	640,980
2019-12-02	Acorda Therapeutics, Inc.S Sale	Director, President and CEO	SSale	−4,699 sh	$1.60	−$7,505.243	607,287
2019-11-07	Acorda Therapeutics, Inc.Employee Stock Option (right to buy)A Award	Director, President and CEO	AAward	+219K sh	—	—	218,500
2019-03-08	Acorda Therapeutics, Inc.A Award	Director, President and CEO	AAward	+25.6K sh	—	—	517,136
2019-03-08	Acorda Therapeutics, Inc.Employee Stock Option (right to buy)A Award	Director, President and CEO	AAward	+42.7K sh	—	—	42,715
2019-02-21	Acorda Therapeutics, Inc.F Tax Payment	Director, President and CEO	FTax Payment	−2,027 sh	$13.38	−$27.1K	491,507
2018-12-22	Acorda Therapeutics, Inc.A Award	Director, President and CEO	AAward	+5,980 sh	—	—	493,534
2018-12-03	Acorda Therapeutics, Inc.S Sale	Director, President and CEO	SSale	−3,620 sh	$20.60	−$74.6K	487,554
2018-11-05	Acorda Therapeutics, Inc.F Tax Payment	Director, President and CEO	FTax Payment	−2,031 sh	$20.28	−$41.2K	491,174
2018-09-10	Acorda Therapeutics, Inc.A Award	Director, President and CEO	AAward	+5,980 sh	—	—	493,205
2018-03-05	Acorda Therapeutics, Inc.Employee Stock Option (right to buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−62.5K sh	—	—	0
2018-03-05	Acorda Therapeutics, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+62.5K sh	$19.81	+$1.24M	588,875
2018-03-05	Acorda Therapeutics, Inc.F Tax Payment	Director, President and CEO	FTax Payment	−24.6K sh	$25.95	−$638K	564,285
2018-02-22	Acorda Therapeutics, Inc.A Award	Director, President and CEO	AAward	+14.7K sh	—	—	526,375
2017-06-16	Acorda Therapeutics, Inc.P Purchase	Director, President and CEO	PPurchase	+20K sh	$16.95	+$339K	511,648
2017-03-01	Acorda Therapeutics, Inc.Employee Stock Option (right to buy)A Award	Director, President and CEO	AAward	+29.9K sh	—	—	29,900
2017-03-01	Acorda Therapeutics, Inc.A Award	Director, President and CEO	AAward	+12K sh	—	—	491,648
2016-12-14	Acorda Therapeutics, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+40.2K sh	$15.49	+$622K	519,860
2016-12-14	Acorda Therapeutics, Inc.S Sale	Director, President and CEO	SSale	−39.8K sh	$20.75	−$825K	480,096
2016-12-14	Acorda Therapeutics, Inc.Employee Stock Option (right to buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−40.2K sh	—	—	0
2016-12-14	Acorda Therapeutics, Inc.S Sale	Director, President and CEO	SSale	−408 sh	$21.35	−$8,710.8	479,688
2016-12-01	Acorda Therapeutics, Inc.S Sale	Director, President and CEO	SSale	−7,160 sh	$20.74	−$148K	479,688
2016-03-02	Acorda Therapeutics, Inc.Employee Stock Option (right to buy)A Award	Director, President and CEO	AAward	+68.7K sh	—	—	68,726
2016-02-04	Acorda Therapeutics, Inc.Employee Stock Option (right to buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−10.6K sh	—	—	40,172
2016-02-04	Acorda Therapeutics, Inc.Employee Stock Option (right to buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−4,005 sh	—	—	0
2016-02-04	Acorda Therapeutics, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+4,005 sh	$6.00	+$24K	419,197
2016-02-04	Acorda Therapeutics, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+10.6K sh	$15.49	+$164K	429,788
2016-02-04	Acorda Therapeutics, Inc.Employee Stock Option (right to buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−14.6K sh	—	—	0
2016-02-04	Acorda Therapeutics, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+14.6K sh	$5.85	+$85.7K	415,192
2016-01-22	DYAX CORPD Disposition to Issuer	Former director	DDisposition to Issuer	−133K sh	—	—	0
2016-01-22	DYAX CORPStock Option (right to buy)D Disposition to Issuer	Former director	DDisposition to Issuer	−16.7K sh	—	—	0
2016-01-15	DYAX CORPStock Option (right to buy)M Exercise/Conversion	Former director	MExercise/Conversion	−33.3K sh	—	—	16,667
2016-01-15	DYAX CORPStock Option (right to buy)M Exercise/Conversion	Former director	MExercise/Conversion	−75K sh	—	—	0
2016-01-15	DYAX CORPM Exercise/Conversion	Former director	MExercise/Conversion	+33.3K sh	$26.23	+$874K	133,333
2016-01-15	DYAX CORPStock Option (right to buy)M Exercise/Conversion	Former director	MExercise/Conversion	−25K sh	—	—	0
2016-01-15	DYAX CORPM Exercise/Conversion	Former director	MExercise/Conversion	+25K sh	$1.35	+$33.8K	25,000
2016-01-15	DYAX CORPM Exercise/Conversion	Former director	MExercise/Conversion	+75K sh	$1.51	+$113K	100,000
2015-12-01	Acorda Therapeutics, Inc.S Sale	Director, President and CEO	SSale	−11.9K sh	$38.08	−$451K	400,550
2015-10-05	Acorda Therapeutics, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+910 sh	$15.49	+$14.1K	413,310
2015-10-05	Acorda Therapeutics, Inc.S Sale	Director, President and CEO	SSale	−910 sh	$30.10	−$27.4K	412,400
2015-10-05	Acorda Therapeutics, Inc.Employee Stock Option (right to buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−910 sh	—	—	50,763
2015-10-02	Acorda Therapeutics, Inc.Employee Stock Option (right to buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−70.4K sh	—	—	14,642
2015-10-02	Acorda Therapeutics, Inc.Employee Stock Option (right to buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−8,811 sh	—	—	4,005

Recent filings

Accepted (ET)
Apr 44
COHEN RON0001209191-23-022754
SEC(opens sec.gov)
Mar 204
COHEN RON0001209191-23-020044
SEC(opens sec.gov)
Mar 214
COHEN RON0001209191-22-020260
SEC(opens sec.gov)
Nov 154
COHEN RON0001209191-21-064465
SEC(opens sec.gov)
Sep 84
COHEN RON0001209191-21-055099
SEC(opens sec.gov)
Mar 54
COHEN RON0001209191-21-018359
SEC(opens sec.gov)
Sep 214
COHEN RON0001209191-20-051239
SEC(opens sec.gov)
Dec 44
COHEN RON0001209191-19-058936
SEC(opens sec.gov)
Nov 124
COHEN RON0001209191-19-055902
SEC(opens sec.gov)
Mar 124
COHEN RON0001209191-19-018789
SEC(opens sec.gov)
Feb 254
COHEN RON0001209191-19-012956
SEC(opens sec.gov)
Dec 274
COHEN RON0001209191-18-064140
SEC(opens sec.gov)
Dec 64
COHEN RON0001209191-18-061102
SEC(opens sec.gov)
Nov 74
COHEN RON0001209191-18-057549
SEC(opens sec.gov)
Sep 124
COHEN RON0001209191-18-050626
SEC(opens sec.gov)
Mar 74
COHEN RON0001209191-18-017581
SEC(opens sec.gov)

Companies

Address

15 SKYLINE DRIVE

HAWTHORNE, NY, 10532